A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants

Clinical trial NCT06188507 · SUSPENDED

Trial details

NCT number: NCT06188507
Sponsor: GlaxoSmithKline
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2024-01-12
Primary completion: 2026-07-14
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.